These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3893732)

  • 21. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
    Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.
    Saper J; Dahlof C; So Y; Tfelt-Hansen P; Malbecq W; Loeys T; Barraclough E; Klipfel M; Lines C; Visser H; Reines S; Yuen E;
    Headache; 2006 Feb; 46(2):264-75. PubMed ID: 16492236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physiopathology of migraine].
    Goadsby PJ; Lance JW
    Rev Prat; 1990 Feb; 40(5):389-93. PubMed ID: 1968676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT3 receptor antagonists and migraine therapy.
    Ferrari MD
    J Neurol; 1991; 238 Suppl 1():S53-6. PubMed ID: 2045832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of MK-462 in migraine.
    Cutler NR; Claghorn J; Sramek JJ; Block G; Panebianco D; Cheng H; Olah TV; Reines SA
    Cephalalgia; 1996 Apr; 16(2):113-6. PubMed ID: 8665577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
    Szumlinski KK; Frys KA; Kalivas PW
    Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW
    Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
    Kankaanpää A; Meririnne E; Seppälä T
    Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flunarizine i.v. in the acute treatment of common or classical migraine attacks--a placebo-controlled double blind trial.
    Soyka D; Taneri Z; Oestreich W; Schmidt R
    Headache; 1989 Jan; 29(1):21-7. PubMed ID: 2647666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
    Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
    Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a traditional syrup from Citrus medica L. fruit juice on migraine headache: A randomized double blind placebo controlled clinical trial.
    Jafarpour M; Yousefi G; Hamedi A; Shariat A; Salehi A; Heydari M
    J Ethnopharmacol; 2016 Feb; 179():170-6. PubMed ID: 26721220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks.
    Stark R; Dahlöf C; Haughie S; Hettiarachchi J;
    Cephalalgia; 2002 Feb; 22(1):23-32. PubMed ID: 11993610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.